alternative to tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Tirzepatide vs Semaglutide: Which is

The FDA approved tirzepatide only as a subcutaneous injection, first as Mounjaro for type 2 diabetes in May 2022, then as Zepbound for chronic weight management in November 2023

Lilly Rx Only NDC 0002-4052-11 Mounjaro (tirzepatide) injection 10 mg/2.4 mL (4.17 mg/mL) ATTENTION: Contains 4 doses of 2.5 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient

Lifestyle Considerations While tirzepatide can facilitate weight loss, it is crucial to remember that it works best when combined with healthy lifestyle changes

Retatrutide (LY3437943) is an investigational compound currently in Phase 3 TRIUMPH clinical trials

The drug improved insulin sensitivity, insulin secretion, and prandial insulin and glucagon concentrations